Tunnah’s musings: Rare diseases hold key to future of drug development
Cambridge Rare Disease Network, CRDN, genomes, patients, pharma, Rare diseases
0 Comment
The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.
